HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term efficacy and safety of Anakinra in a patient with liver transplant due to Adult onset Still's Disease.

AuthorsSedat Yilmaz, Muhammet Cinar, Ismail Simsek, Hakan Erdem, Salih Pay
JournalModern rheumatology (Mod Rheumatol) Vol. 24 Issue 6 Pg. 1030-1 (Nov 2014) ISSN: 1439-7609 [Electronic] England
PMID24313885 (Publication Type: Case Reports, Letter)
Chemical References
  • Antirheumatic Agents
  • Interleukin 1 Receptor Antagonist Protein
Topics
  • Adult
  • Antirheumatic Agents (adverse effects, therapeutic use)
  • Humans
  • Interleukin 1 Receptor Antagonist Protein (adverse effects, therapeutic use)
  • Liver Failure (etiology, surgery)
  • Liver Transplantation
  • Male
  • Recurrence
  • Still's Disease, Adult-Onset (complications, drug therapy, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: